202 related articles for article (PubMed ID: 26022081)
21. High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones.
Hager S; Pape VFS; Pósa V; Montsch B; Uhlik L; Szakács G; Tóth S; Jabronka N; Keppler BK; Kowol CR; Enyedy ÉA; Heffeter P
Antioxid Redox Signal; 2020 Aug; 33(6):395-414. PubMed ID: 32336116
[No Abstract] [Full Text] [Related]
22. Copper-Containing Nanoparticles and Organic Complexes: Metal Reduction Triggers Rapid Cell Death via Oxidative Burst.
Tsymbal SA; Moiseeva AA; Agadzhanian NA; Efimova SS; Markova AA; Guk DA; Krasnovskaya OO; Alpatova VM; Zaitsev AV; Shibaeva AV; Tatarskiy VV; Dukhinova MS; Ol'shevskaya VA; Ostroumova OS; Beloglazkina EK; Shtil AA
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681725
[TBL] [Abstract][Full Text] [Related]
23. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells.
Nagai M; Vo NH; Shin Ogawa L; Chimmanamada D; Inoue T; Chu J; Beaudette-Zlatanova BC; Lu R; Blackman RK; Barsoum J; Koya K; Wada Y
Free Radic Biol Med; 2012 May; 52(10):2142-50. PubMed ID: 22542443
[TBL] [Abstract][Full Text] [Related]
24. Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
Stefani C; Jansson PJ; Gutierrez E; Bernhardt PV; Richardson DR; Kalinowski DS
J Med Chem; 2013 Jan; 56(1):357-70. PubMed ID: 23276209
[TBL] [Abstract][Full Text] [Related]
25. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity of expanded coordination bis-thiosemicarbazones and copper complexes thereof.
Akladios FN; Andrew SD; Parkinson CJ
J Biol Inorg Chem; 2016 Dec; 21(8):931-944. PubMed ID: 27645502
[TBL] [Abstract][Full Text] [Related]
27. Effects of copper overload in P19 neurons: impairment of glutathione redox homeostasis and crosstalk between caspase and calpain protease systems in ROS-induced apoptosis.
Jazvinšćak Jembrek M; Vlainić J; Radovanović V; Erhardt J; Oršolić N
Biometals; 2014 Dec; 27(6):1303-22. PubMed ID: 25216733
[TBL] [Abstract][Full Text] [Related]
28. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
29. Effect of novel dinuclear platinum(II) complexes on redox status of MOLT-4 leukemic cells.
Jarocka I; Gęgotek A; Bielawska A; Bielawski K; Łuczaj W; Hodun T; Skrzydlewska E
Toxicol Mech Methods; 2013 Nov; 23(9):641-9. PubMed ID: 23859055
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II).
Yadav AA; Patel D; Wu X; Hasinoff BB
J Inorg Biochem; 2013 Sep; 126():1-6. PubMed ID: 23707906
[TBL] [Abstract][Full Text] [Related]
31. Iron, copper, and manganese complexes with in vitro superoxide dismutase and/or catalase activities that keep Saccharomyces cerevisiae cells alive under severe oxidative stress.
Ribeiro TP; Fernandes C; Melo KV; Ferreira SS; Lessa JA; Franco RW; Schenk G; Pereira MD; Horn A
Free Radic Biol Med; 2015 Mar; 80():67-76. PubMed ID: 25511255
[TBL] [Abstract][Full Text] [Related]
32. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
[TBL] [Abstract][Full Text] [Related]
33. Targeting redox vulnerability of cancer cells by prooxidative intervention of a glutathione-activated Cu(II) pro-ionophore: Hitting three birds with one stone.
Bao XZ; Dai F; Li XR; Zhou B
Free Radic Biol Med; 2018 Aug; 124():342-352. PubMed ID: 29935260
[TBL] [Abstract][Full Text] [Related]
34. Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action.
Haynes RK; Chan WC; Wong HN; Li KY; Wu WK; Fan KM; Sung HH; Williams ID; Prosperi D; Melato S; Coghi P; Monti D
ChemMedChem; 2010 Aug; 5(8):1282-99. PubMed ID: 20629071
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
Smith DG; Magwere T; Burchill SA
Expert Rev Anticancer Ther; 2011 Feb; 11(2):229-49. PubMed ID: 21342042
[TBL] [Abstract][Full Text] [Related]
36. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.
Kowol CR; Heffeter P; Miklos W; Gille L; Trondl R; Cappellacci L; Berger W; Keppler BK
J Biol Inorg Chem; 2012 Mar; 17(3):409-23. PubMed ID: 22189939
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
Potůčková E; Roh J; Macháček M; Sahni S; Stariat J; Šesták V; Jansová H; Hašková P; Jirkovská A; Vávrová K; Kovaříková P; Kalinowski DS; Richardson DR; Šimůnek T
PLoS One; 2015; 10(10):e0139929. PubMed ID: 26460540
[TBL] [Abstract][Full Text] [Related]
39. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells.
Ji Y; Dai F; Zhou B
Free Radic Biol Med; 2018 Dec; 129():215-226. PubMed ID: 30240704
[TBL] [Abstract][Full Text] [Related]
40. Advances in metal-induced oxidative stress and human disease.
Jomova K; Valko M
Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
